Skip to main content
Log in

Development and Evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

This study compared the release behavior of single-unit (tablets, capsules) and multiple-unit (minitablets in capsules) controlled-release systems of furosemide. The swelling and erosion behaviors of these systems, which contained the swellable hydrophilic polymers sodium alginate (high viscosity) and Carbopol 974P, were compared. Swelling and erosion experiments showed a high degree of swelling and limited erosion for the Carbopol preparations, whereas less swelling but greater erosion was observed for the sodium alginate preparations. The sodium alginate preparations were eroded in 6 hours, while Carbopol preparations exhibited limited erosion within this period of time. These results appear to be attributed to the physicochemical characteristics of the polymers used in this study. Polymer characteristics greatly influenced the release of furosemide (model drug) from the formulations prepared and tested. Sodium alginate had a less pronounced sustained release effect compared with Carbopol (ie, in 8 hours all 3 sodium alginate dosage forms displayed complete release of furosemide, while only 30% of the drug was released from Carbopol dosage forms). Finally, all 3 Carbopol dosage forms (single- and multiple-unit) displayed similar release behavior while sodium alginate dosage forms displayed a different and more distinctive behavior. Minitablets and tablets showed a greater sustained release effect compared with capsules. Evaluation of the release data indicates that the release mechanism for sodium alginate formulations may be attributed to erosion/dissolution, while for Carbopol it may be attributed mainly to polymer relaxation and diffusion of the drug from the polymer surface.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Follonier N, Doelker E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms.STP Pharma Sciences. 1992;2:141–155.

    CAS  Google Scholar 

  2. Vial-Bernasconi AC, Doelker E, Buri P. Prolonged release capsules: divided and monolithic forms.STP Pharma Sciences. 1988;4;397–409.

    CAS  Google Scholar 

  3. Fan LT, Singh SK. Introduction. In: Fan LT, Singh SK, eds. Controlled Release-A Quantitative Treatment. Berlin, Germany: Springer-Verlag; 1989:4–5.

    Google Scholar 

  4. Fan LT, Singh SK. Diffusion-controlled release In: Fan LT, Singh SK, eds. Controlled Release-A Quantitative Treatment. Berlin, Germany: Springer-Verlag; 1989:61–79.

    Google Scholar 

  5. Fan LT, Singh SK. Introduction. In: Fan LT, Singh SK, eds. Controlled Release-A Quantitative Treatment. Berlin, Germany: Springer-Verlag; 1989:3.

    Google Scholar 

  6. Ojantakanen S. Effect of viscosity grade of polymer additive and compression force on release of ibuprofen from hard gelatin capsules. Acta Pharm Fenn. 1992;101:119–126.

    CAS  Google Scholar 

  7. Efentakis M, Vlachou, M. Evaluation of high molecular weight poly(oxyethylene) (polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled release hard gelatin capsules. Pharm Dev Technol. 2000;5:339–346.

    Article  CAS  Google Scholar 

  8. Digenis GA. The in vivo behavior of multiparticulate versus single unit dosage formulations. In: Ghebre-Sellassie I, ed. Multipaticulate Oral Drug Delivery. New York: Marcel Dekker, Inc.; 1994:333–355.

    Google Scholar 

  9. Celik M. Compaction of multiparticulate oral dosage forms. In: Ghebre-Sellassie I, ed. Multipaticulate Oral Drug Delivery. New York: Marcel Dekker, Inc.; 1994: 181–215.

    Google Scholar 

  10. Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.Pharm Res. 1991;8;360–364.

    Article  CAS  Google Scholar 

  11. Lowman AM, Peppas NA. Hydrogels. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. New York: John Wiley and Sons, Inc.; 1999:407.

    Google Scholar 

  12. Alderman D. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms.Int J Pharm Technol Prod Manuf. 1984:5;1–9.

    CAS  Google Scholar 

  13. Hogan JE. Hydropropylmethycellulose sustained release technology.Drug Dev Ind Pharm. 1989;15;975–999.

    Article  CAS  Google Scholar 

  14. McNeely W, Pettitt D. Alginates. In: Whistler R, Bemiller J, eds. Industrial Gums. New York: Academic Press; 1973:68–71.

    Google Scholar 

  15. Sugawara S, Imai T, Otagiri M. The controlled release of prednisolone using alginate gel.Pharm Res. 1994;11;272–277.

    Article  CAS  Google Scholar 

  16. Controlled release tablets and capsules. Carbopol Technical Bulletin. 1994;17:1–27.

    Google Scholar 

  17. Perez-Marcos B, Ford JL, Armstrong DJ, Elliot PN, Rostron C, Hogan JE. Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxypropyl methylcellulose K4M and Carbopol 974.J Pharm Sci. 1996;85:330–334.

    Article  CAS  Google Scholar 

  18. Apicella A, Cappello B, Del Nobile M, La Rontonda MI, Mensitieri G, Nicolais L. Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release.Biomaterials. 1993;14:83–91.

    Article  CAS  Google Scholar 

  19. Khan Z, Jiabi Z. Formulation and in vitro evaluation of ibuprofen-carbopol 974-NF controlled release matrix tablets.J. Control Release. 1998;54:185–190.

    Article  CAS  Google Scholar 

  20. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas, NA. Mechanisms of solute release from porous hydrophilic polymers.Int J Pharm. 1983;15:25–35.

    Article  CAS  Google Scholar 

  21. Khan K. The concept of dissolution efficiency.J Pharm Pharmacol. 1975;27:48–49.

    CAS  Google Scholar 

  22. Prasad V, Rapaka R, Knight P, Cabana B. Dissolution medium: a critical parameter to identify bioavailability problems of furosemide tablets.Int J Pharm. 1982;11:81–92

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manuel Efentakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Efentakis, M., Koutlis, A. & Vlachou, M. Development and Evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems. AAPS PharmSciTech 1, 34 (2000). https://doi.org/10.1208/pt010434

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt010434

KeyWords

Navigation